344 related articles for article (PubMed ID: 34256965)
21. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
22. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life among patients with knee osteoarthritis in Guangzhou, China: a multicenter cross-sectional study.
Chang J; Yuan Y; Fu M; Wang D
Health Qual Life Outcomes; 2023 May; 21(1):50. PubMed ID: 37244981
[TBL] [Abstract][Full Text] [Related]
24. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
25. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
26. Australian population norms for health-related quality of life measured using the EQ-5D-5L, and relationships with sociodemographic characteristics.
Redwood L; Currow D; Kochovska S; Thomas SJ
Qual Life Res; 2024 Mar; 33(3):721-733. PubMed ID: 38085452
[TBL] [Abstract][Full Text] [Related]
27. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
[TBL] [Abstract][Full Text] [Related]
28. Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS; Ray S; Ganguli A; Cella D
Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
[TBL] [Abstract][Full Text] [Related]
29. Quality of life of caregivers of breast cancer patients: a cross-sectional evaluation.
Clarijs ME; Oemrawsingh A; Bröker MEE; Verhoef C; Lingsma H; Koppert LB
Health Qual Life Outcomes; 2022 Feb; 20(1):29. PubMed ID: 35183212
[TBL] [Abstract][Full Text] [Related]
30. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
Yang Q; Yu XX; Zhang W; Li H
Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
[TBL] [Abstract][Full Text] [Related]
31. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Wakumoto Y; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Funagoshi M; Arakawa I; Noto S; Shimozuma K
Qual Life Res; 2020 Mar; 29(3):755-763. PubMed ID: 31583618
[TBL] [Abstract][Full Text] [Related]
32. US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples.
Jiang R; Janssen MFB; Pickard AS
Qual Life Res; 2021 Mar; 30(3):803-816. PubMed ID: 33025373
[TBL] [Abstract][Full Text] [Related]
33. Application of EQ-5D-5L questionnaire in patients suffering from urinary incontinence.
Garcia-Gordillo MA; Collado-Mateo D; Olivares PR; Adsuar JC
Actas Urol Esp; 2016 Sep; 40(7):457-62. PubMed ID: 26975979
[TBL] [Abstract][Full Text] [Related]
34. The use of EQ-5D-5L as a patient-reported outcome measure in evaluating community rehabilitation services in Alberta, Canada.
Short H; Al Sayah F; Churchill K; Keogh E; Warner L; Ohinmaa A; Johnson JA
Health Qual Life Outcomes; 2023 Nov; 21(1):125. PubMed ID: 37978502
[TBL] [Abstract][Full Text] [Related]
35. Norwegian population norms for the EQ-5D-5L: results from a general population survey.
Garratt AM; Hansen TM; Augestad LA; Rand K; Stavem K
Qual Life Res; 2022 Feb; 31(2):517-526. PubMed ID: 34272631
[TBL] [Abstract][Full Text] [Related]
36. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
37. Performance of the EQ-5D in patients with irritable bowel syndrome.
Bushnell DM; Martin ML; Ricci JF; Bracco A
Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
[TBL] [Abstract][Full Text] [Related]
38. Measurement of Health-Related Quality of Life in Individuals With Rare Diseases in China: Nation-Wide Online Survey.
Xu RH; Ng SSM; Luo N; Dong D; Zhang S
JMIR Public Health Surveill; 2023 Oct; 9():e50147. PubMed ID: 37906229
[TBL] [Abstract][Full Text] [Related]
39. EQ-5D-5L norms for the urban Chinese population in China.
Yang Z; Busschbach J; Liu G; Luo N
Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
[TBL] [Abstract][Full Text] [Related]
40. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
Gray LA; Wailoo AJ; Hernandez Alava M
Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
